Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease

British Journal of Ophthalmology

Volumn 95, Issue 11, 2011, Pages 1542-1546

  Quek, Desmond Tung Lien ^a,b   Jap, Aliza ^a,c   Chee, Soon Phaik ^a,b,d  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c CHANGI GENERAL HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE;

ADULT; ARTICLE; CATARACT; CATARACT EXTRACTION; DEMOGRAPHY; DRUG MEGADOSE; DRUG USE; EXTRACAPSULAR CATARACT EXTRACTION; FEMALE; FOLLOW UP; HUMAN; IRIDECTOMY; LENS IMPLANTATION; LENS SUBLUXATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; AGED; CATARACT; CATARACT EXTRACTION; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOCORTICOIDS; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME; UVEOMENINGOENCEPHALITIC SYNDROME; VISION DISORDERS; VISUAL ACUITY; YOUNG ADULT;

EID: 80054896022     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.184796     Document Type: Article

References (20)

1. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-92.
2. Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980;90:69-75. (Pubitemid 10033933)
3. Fang W, Yang P. Vogt-Koyanagi-Harada syndrome. Curr Eye Res 2008;33:517-23. (Pubitemid 351948483)
4. Rao NA. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye 1997;11(Pt 2):213-16. (Pubitemid 27249915)
5. Sakamoto T, Murata T, Inomata H. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease. Arch Ophthalmol 1991;109:1270-4.
6. Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
7. Moorthy RS, Rajeev B, Smith RE, et al. Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1994;118:197-204. (Pubitemid 24242453)
8. Ganesh SK, Padmaja BK, Biswas J. Cataract surgery in patients with Vogt-Koyanagi-Harada syndrome. J Cataract Refract Surg 2004;30:95-100. (Pubitemid 38234337)
9. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52. (Pubitemid 32422124)
10. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140:509-16. (Pubitemid 41224845)
11. Foster RE, Lowder CY, Meisler DM, et al. Extracapsular cataract extraction and posterior chamber intraocular lens implantation in uveitis patients. Ophthalmology 1992;99:1234-41.
12. Heger H, Drolsum L, Haaskjold E. Cataract surgery with implantation of IOL in patients with uveitis. Acta Ophthalmol (Copenh) 1994;72:478-82. (Pubitemid 24302819)
13. Okhravi N, Lightman SL, Towler HM. Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology 1999;106:710-22. (Pubitemid 30194311)
14. Elgohary MA, McCluskey PJ, Towler HM, et al. Outcome of phacoemulsification in patients with uveitis. Br J Ophthalmol 2007;91:916-21. (Pubitemid 47013105)
15. Belair ML, Kim SJ, Thorne JE, et al. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol 2009;148:128-35 e2.
16. Rutzen AR, Ortega-Larrocea G, Frambach DA, et al. Macular edema in chronic Vogt-Koyanagi-Harada syndrome. Retina 1995;15:475-9. (Pubitemid 26002414)
17. Wolf EJ, Braunstein A, Shih C, et al. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac. J Cataract Refract Surg 2007;33:1546-9. (Pubitemid 47299181)
18. Warren KA, Bahrani H, Fox JE. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. Retina 2010;30:260-6.
19. Dana MR, Chatzistefanou K, Schaumberg DA, et al. Posterior capsule opacification after cataract surgery in patients with uveitis. Ophthalmology 1997;104:1387-93; discussion 1393-4.
20. Findl O, Buehl W, Bauer P, et al. Interventions for preventing posterior capsule opacification. Cochrane Database Syst Rev 2010;17(2):CD003738.